Invesco’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-155,206
Closed -$15.8M 3774
2025
Q4
$15.8M Sell
155,206
-141,227
-48% -$11.3M ﹤0.01% 1589
2025
Q3
$16.2M Buy
296,433
+9,669
+3% +$483K ﹤0.01% 1561
2025
Q2
$15.2M Sell
286,764
-91,887
-24% -$4.67M ﹤0.01% 1558
2025
Q1
$16.4M Sell
378,651
-1,032
-0.3% -$52.3K ﹤0.01% 1531
2024
Q4
$21.3M Buy
379,683
+138,089
+57% +$8.59M ﹤0.01% 1452
2024
Q3
$16.5M Sell
241,594
-1,871
-0.8% -$106K ﹤0.01% 1575
2024
Q2
$10.3M Sell
243,465
-21,819
-8% -$1.2M ﹤0.01% 1773
2024
Q1
$18.3M Sell
265,284
-1,926,292
-88% -$122M ﹤0.01% 1504
2023
Q4
$162M Buy
2,191,576
+11,789
+0.5% +$773K 0.04% 606
2023
Q3
$149M Sell
2,179,787
-813,055
-27% -$69M 0.04% 592
2023
Q2
$281M Buy
2,992,842
+790,334
+36% +$61.7M 0.07% 366
2023
Q1
$149M Buy
2,202,508
+186,498
+9% +$12M 0.04% 574
2022
Q4
$99.8M Buy
2,016,010
+6,201
+0.3% +$253K 0.03% 710
2022
Q3
$65.3M Sell
2,009,809
-7,864
-0.4% -$324K 0.02% 808
2022
Q2
$79.5M Buy
2,017,673
+39,682
+2% +$2.12M 0.02% 765
2022
Q1
$138M Buy
1,977,991
+31,061
+2% +$2.27M 0.04% 654
2021
Q4
$152M Sell
1,946,930
-496
-0% -$43.8K 0.04% 623
2021
Q3
$186M Sell
1,947,426
-88,575
-4% -$9.35M 0.05% 538
2021
Q2
$253M Sell
2,036,001
-18,060
-0.9% -$2.16M 0.06% 409
2021
Q1
$271M Sell
2,054,061
-241,845
-11% -$33.1M 0.07% 347
2020
Q4
$304M Sell
2,295,906
-526,460
-19% -$63.7M 0.09% 275
2020
Q3
$288M Sell
2,822,366
-4,123
-0.1% -$356K 0.1% 244
2020
Q2
$246M Buy
2,826,489
+124
+0% +$9.91K 0.09% 267
2020
Q1
$164M Buy
2,826,365
+9,827
+0.3% +$798K 0.07% 336
2019
Q4
$260M Sell
2,816,538
-333,769
-11% -$29.3M 0.08% 307
2019
Q3
$285M Buy
3,150,307
+7,281
+0.2% +$830K 0.07% 324
2019
Q2
$371M Buy
3,143,026
+2,634,078
+518% +$265M 0.1% 244
2019
Q1
$44.1M Sell
508,948
-37,021
-7% -$3.15M 0.01% 868
2018
Q4
$34.5M Sell
545,969
-115,693
-17% -$7.94M 0.01% 913
2018
Q3
$52.2M Sell
661,662
-402,123
-38% -$26.2M 0.02% 845
2018
Q2
$63.6M Buy
1,063,785
+120,705
+13% +$6.5M 0.02% 737
2018
Q1
$38M Sell
943,080
-196,009
-17% -$9.56M 0.01% 864
2017
Q4
$59.8M Buy
1,139,089
+168,061
+17% +$8.97M 0.02% 691
2017
Q3
$45.8M Buy
971,028
+48,862
+5% +$1.97M 0.02% 806
2017
Q2
$32.6M Buy
922,166
+319,170
+53% +$9.85M 0.01% 973
2017
Q1
$14.2M Sell
602,996
-250,302
-29% -$4.96M ﹤0.01% 1355
2016
Q4
$11.4M Buy
853,298
+568,361
+199% +$9.18M ﹤0.01% 1452
2016
Q3
$5.29M Buy
284,937
+257,943
+956% +$4.55M ﹤0.01% 1938
2016
Q2
$331K Sell
26,994
-2,542
-9% -$19.1K ﹤0.01% 3386
2016
Q1
$199K Sell
29,536
-469,692
-94% -$3M ﹤0.01% 3561
2015
Q4
$4.61M Sell
499,228
-2,857,204
-85% -$26.6M ﹤0.01% 1961
2015
Q3
$60.4M Sell
3,356,432
-210,000
-6% -$4.82M 0.03% 661
2015
Q2
$106M Sell
3,566,432
-88,221
-2% -$2.22M 0.04% 493
2015
Q1
$80.5M Sell
3,654,653
-226,509
-6% -$5.75M 0.03% 599
2014
Q4
$106M Sell
3,881,162
-366,887
-9% -$8.93M 0.04% 496
2014
Q3
$82.3M Sell
4,248,049
-200,242
-5% -$3.67M 0.03% 567
2014
Q2
$75.8M Buy
4,448,291
+1,288,222
+41% +$17.7M 0.03% 619
2014
Q1
$44.8M Buy
3,160,069
+1,974,060
+166% +$26.7M 0.02% 835
2013
Q4
$13.9M Sell
1,186,009
-572,288
-33% -$6.57M 0.01% 1361
2013
Q3
$20.7M Buy
1,758,297
+450,266
+34% +$5.78M 0.01% 1143
2013
Q2
$18.2M Buy
+1,308,031
New +$14.2M 0.01% 1138

Other funds holding EXAS

Invesco's EXAS Position: Q1 2026 in Review

Invesco sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 155,206 shares — an estimated $15.8M sold.

Invesco first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $371M in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Invesco reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Invesco sold 155,206 Exact Sciences shares in Q1 2026, an estimated $15.8M.
  • Invesco first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Invesco's Exact Sciences position peaked at $371M in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.